Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice

Toxicology

Volumn 201, Issue 1-3, 2004, Pages 133-142

  Takano, Fumihide ^a,b   Tanaka, Tomoaki ^a   Aoi, Jiro ^a   Yahagi, Nobuo ^a   Fushiya, Shinji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

(+) Catechin; Hematotoxicity; Leukocytes; Myelotoxicity; Proliferation; Protection

Indexed keywords

ACTINIDIA ARGUTA EXTRACT; ANTINEOPLASTIC AGENT; CATECHIN; CD11B ANTIGEN; FLUOROURACIL; HERBACEOUS AGENT; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ACTINIDIA ARGUTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD TOXICITY; BONE MARROW CELL; BONE MARROW SUPPRESSION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; LEUKOCYTE; MEDICINAL PLANT; MITOSIS INHIBITION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; BLOOD; BONE MARROW; CATECHIN; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; SPLEEN;

ACTINIDIA; ACTINIDIA ARGUTA; ACTINIDIACEAE;

EID: 3543075116     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.04.009     Document Type: Article

References (28)

1. Buchsel P.C., Forgey A., Grape F.B., Hamann S.S. Granulocyte macrophage colony-stimulating factor: current practice and novel approaches. Clin. J. Oncol. Nurs. 6:2002;198-205
2. Clark S.C., Kamen R. The human hematopoietic colony-stimulating factors. Science. 236:1987;1229-1237
3. Danova M., Aglietta M. Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors. Hematologica. 82:1997;622-629
4. Down J.D., Ploemacher R.E. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp. Hematol. 21:1993;913-921
5. Farese A.M., Williams D.E., Seiler F.R., MacVittie T.J. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood. 82:1993;3012-3018
6. Galmiche M.C., Vogel C.A., Delaloye A.B., Schmidt P.M., Healy F., Mach J.P., Buchegger F. Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice. Exp. Hematol. 24:1996;1298-1306
7. Gentile P., Epremian B.E. Approaches to ablating the myelotoxicity of chemotherapy. Crit. Rev. Oncol. Hematol. 7:1987;71-77
8. Griggs J.J. Reducing the toxicity of anticancer therapy: new strategies. Leuk. Res. 22(Suppl. 1):1998;S27-S33
9. Harrison S.D. Jr., Denine E.P., Peckham J.C. Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fuorouracil in BDF mice. Cancer Treat. Rep. 62:1978;533-545
10. Harrison D., Lerner C. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood. 78:1991;1237-1240
11. Hisha H., Yamada H., Sakurai M.H., Kiyohara H., Li Y., Yu C., Takemoto N., Kawamura H., Yamaura K., Shinohara S., Komatsu Y., Aburada M., Ikehara S. Isolation and identification of hematopoietic stem cell-stimulating substances from Kampo (Japanese herbal) medicine Juzen-taiho-to. Blood. 90:1997;1020-1030
12. Ildstad S.T., Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 307:1984;168
13. Jones A.T., Ziltener H.J. Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies. Blood. 82:1993;1133-1141
14. Kaneko M., Kawakita T., Kumazawa Y., Takimoto H., Nomoto K., Yoshikawa T. Accelerate recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herb drug Hochu-ekkii-to. Immunopharmacology. 44:1999;223-231
15. Kijas J.M., Bauer T.R. Jr., Gafvert S., Marklund S., Trowald-Wigh G., Johannisson A., Hedhammar A., Binns M., Juneja R.K., Hickstein D.D., Andersson L. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics. 61:1999;101-107
16. Kojima S., Takaba K., Kimoto N., Takeda T., Kakuni M., Mizutani M., Suzuki K., Sato H., Hara T. Protective effects of glutathione on 5-fluorouracil-induced myelosuppression in mice. Arch. Toxicol. 77:2003;285-290
17. Lerner C., Harrison D. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 8:1990;114-118
18. Macdonald J.S. Toxicity of 5-fuorouracil. Oncology. 13:1999;33-34
19. Macey M.G., McCarthy D.A., Milne T., Cavenagh J.D., Newland A.C. Comparative study of five commercial reagents for preparing normal and leukaemic Lymphocytes for immunophenotypic analysis by Flow Cytometry. Cytometry. 38:1999;153-160
20. Mangi M.H., Newland A.C. Interleukin-3 in hematology and oncology: current state of knowledge and future directions. Cytokines Mol. Ther. 5:1999;87-95
21. Nabeya, K., Ri, S., 1983. Effects of oriental medical herbs on the restoration of the human body before and after operation. In: Proceedings of the Symposium of Wakan-Yaku, vol. 16, Japan, pp. 201-208.
22. Nand S., Sosman J., Godwin J.E., Fisher R.I. A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood. 83:1994;357-360
23. Ninomiya Y., Ryu M., Matsuura N., Fujimoto K., Miwa M., Ishitsuka H. Antitumor activity and the toxicity on the immune system and intestine of fuorinated pyrimidines, FUra, 5′-DFUR, tegafur and UFT. Jpn. J. Cancer Chemother. 15:1988;1747-1754
24. Schuetz J.D., Wallace H.J., Diasio R.B. 5-Fuorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Res. 44:1984;1358-1363
25. Springer T.A., Thompson W.S., Miller L.J., Schmalstieg F.C., Anderson D.C. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J. Exp. Med. 160:1984;1901-1918
26. Takano F., Tanaka T., Tsukamoto E., Yahagi N., Fushiya S. Isolation of (+)-catechin and (-)-epicatechin from Actinidia arguta as bone marrow cell proliferation promoting compounds. Planta Med. 61:2003;321-326
27. Takatsuki F., Miyasaka Y., Kikuchi T., Suzuki M., Hamuro J. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents. Exp. Hematol. 24:1996;416-422
28. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogensis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21:2001;381-406